CLYM vs SVRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

CLYM

51.6
AI Score
VS
SVRA Wins

SVRA

55.3
AI Score

Investment Advisor Scores

CLYM

52score
Recommendation
HOLD

SVRA

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLYM SVRA Winner
Net Income -27.22M -49.62M CLYM
Operating Income -30.57M -49.30M CLYM
ROE -11.4% -77.1% CLYM
ROA -11.1% -50.8% CLYM
Total Assets 246.29M 97.75M CLYM
Cash 44.11M 22.88M CLYM
Current Ratio 31.45 10.41 CLYM
Free Cash Flow -25.18M -39.88M CLYM

Relative Price Performance (Last 90 Days)

CLYM 1M: -27.3% · 3M: -17.6% SVRA 1M: -11.9% · 3M: -22.4%

Current Technical Phase

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $10.94

SVRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.0%), weak momentum, RSI 35

RSI (14): 35.4 · Price: $4.81

Fundamentals Snapshot

Metric CLYM SVRA
Market Cap — —
Forward P/E -10.9 -15.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — -86843.0%
Operating Margin 0.0% 0.0%
EPS -0.79 -0.58
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SVRA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.